Aurobindo Pharma promoters raise Rs 2k cr to fund realty, other asset buys
The transaction is split into two parts. The Rs 650 crore Series 1 comes with a 24-month tenor and a two-year put and call option, and Rs 1,450 crore, which will be Series 2 with a four-year tenor. Series 1 will carry a coupon of 11.75%, while Ser...
The transaction is split into two parts. The ₹650 crore Series 1 comes with a 24-month tenor and a two-year put and call option, and ₹1,450 crore, which will be Series 2 with a four-year tenor.
Series 1 will carry a coupon of 11.75%, while Series 2 is likely to be priced at 15.5%.
The debt is backed by a pledge of promoter special purpose vehicles- Raidurgam Developers and Auro Realty - along with other hard collateral. These assets are together valued at more than ₹2,500 crore, supported by personal and corporate guarantees.
Raidurgam Developers (RDL) is the entity managing the Galaxy Tower project in Raidurgam, a Hyderabad suburb that is home to several high-tech companies. The collateral cover stands at nearly 2.5x, rising to around 4x with the other guarantees.

A spokesperson of Aurobindo Pharma did not respond to requests for comment.
Aurobindo Pharma reported revenues of around ₹31,000 crore and remains net cash positive.
Promoters have been raising funds from alternate credit funds and private credit funds in high-yield money for various purposes. Last year, Kalyan Jewellers India's promoter, TS Kalyanarama, and promoter group had raised funds from funds including Motilal Oswal, 360 One in high-yield debt to increase their stake by acquiring a 2.36% from Warburg Pincus. The promoters have also pledged additional shares to secure loans from various financial institutions.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.